At present, some clinical trials have addressed the use of ALDH inhibitors in glioblastoma treatment, mostly centered in the use of the Disulfiram/Copper combination with TMZ (NCT01777919, NCT01907165, NCT02715609). Here, LDHA is linked to glioblastoma.